BIOQ (BIOQ) Stock Price & Analysis
BIOQ (BIOQ) rose 7.69% to USD 35 as of June 10, 2026 at 07:21 UTC, according to Nexqual real-time market data.
BIOQ last closed at USD 32.5; the session ranged USD 35–35 on volume of 103 shares. Market capitalization is $31.30M, with a 52-week range of USD 32.5–44.25 (OID). Source: Nexqual, June 10, 2026 at 07:21 UTC.
Key Statistics (as of June 10, 2026 at 07:21 UTC)
| Price | USD 35 |
|---|---|
| Change | ▲ 7.69% (up) |
| Previous Close | USD 32.5 |
| Open | USD 35 |
| Day Range | USD 35 – 35 |
| 52-Week Range | USD 32.5 – 44.25 |
| Volume | 103 shares |
| Market Cap | $31.30M |
| Exchange | OID |
Technical Analysis (BIOQ)
Nexqual's technical model rates BIOQ "SELL" based on 2 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 07:21 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 0 (oversold) |
| vs SMA50 | Below (USD 36.08) |
| MACD | -1.1 (negative) |
Analyst Ratings (BIOQ)
Wall Street analysts rate BIOQ "None", per Nexqual as of June 10, 2026 at 07:21 UTC.
| Consensus Rating | None |
|---|
Earnings (BIOQ)
Source: Nexqual, June 10, 2026 at 07:21 UTC.
Financials & Fundamentals (BIOQ)
| Total Revenue | $42.35M |
|---|---|
| Revenue Growth (YoY) | -29.90% |
| Gross Margin | +19.06% |
| Operating Margin | -12.61% |
| Profit Margin | -2.92% |
| ROE | -3.47% |
| Debt / Equity | 95.61 |
| Current Ratio | 4.01 |
| Total Cash | $13.29M |
| Total Debt | $33.48M |
| Free Cash Flow | $12.06M |
Source: Nexqual, June 10, 2026 at 07:21 UTC.
Financial Health Score (BIOQ)
Nexqual rates BIOQ's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 07:21 UTC.
| Growth | Critical — Revenue -30% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $13M cash vs $33M debt |
| Cash Flow | Strong — FCF $12M, 28% margin |
| Efficiency | Critical — ROE -3%, ROA -2.2% |
Ownership (BIOQ)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 894,416 |
| Float | 205,671 |
Source: Nexqual, June 10, 2026 at 07:21 UTC.
Leadership (BIOQ)
BIOQ is led by Hanne Andersen-Elyard, President & Chief Scientific Officer, per Nexqual as of June 10, 2026 at 07:21 UTC.
| President & Chief Scientific Officer | Hanne Andersen-Elyard |
|---|---|
| Chief Financial Officer | Charles C. Kirk Jr. |
| COO & Secretary | Mitchell L. Franklin |
Major Backers & Investors (BIOQ)
Notable institutional backers of BIOQ include Bip Wealth, LLC , according to Nexqual as of June 10, 2026 at 07:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Bip Wealth, LLC | 0.29% |
Source: Nexqual, June 10, 2026 at 07:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KSBI | K S Bancorp, Inc. | USD 78.48 | ▲ 0% |
| BTQNF | BQE Water, Inc. | USD 54.66 | ▲ 0% |
| BWTL | Bowlin Travel Centers, Inc. | USD 4 | ▲ 0% |
| CBKM | Consumers Bancorp, Inc. | USD 28 | ▼ 0.88% |
| RTMAF | Reitmans (Canada) Limited | USD 1.4 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:21 UTC. This page is informational and not investment advice.